Total Payments
$5,323
2024 Payments
$224.36
Companies
34
Transactions
348
Medicare Patients
3,861
Medicare Billing
$192,843
Payment Breakdown by Category
Food & Beverage$5,301 (99.6%)
Education$22.25 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,301 | 344 | 99.6% |
| Education | $22.25 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $995.81 | 52 | $0 (2023) |
| PFIZER INC. | $823.39 | 58 | $0 (2024) |
| Amgen Inc. | $442.11 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $366.01 | 46 | $0 (2019) |
| GlaxoSmithKline, LLC. | $286.12 | 17 | $0 (2022) |
| Novo Nordisk Inc | $221.08 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $219.74 | 13 | $0 (2024) |
| ABBVIE INC. | $180.50 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $177.65 | 12 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $171.32 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $224.36 | 11 | ABBVIE INC. ($61.47) |
| 2023 | $284.84 | 14 | Celgene Corporation ($80.97) |
| 2022 | $234.43 | 13 | ABBVIE INC. ($67.03) |
| 2021 | $53.69 | 3 | AbbVie Inc. ($23.50) |
| 2020 | $391.07 | 22 | AstraZeneca Pharmaceuticals LP ($114.48) |
| 2019 | $1,438 | 97 | AstraZeneca Pharmaceuticals LP ($296.63) |
| 2018 | $1,547 | 105 | AstraZeneca Pharmaceuticals LP ($299.25) |
| 2017 | $1,150 | 83 | AstraZeneca Pharmaceuticals LP ($244.84) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Oncology | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Obesity | ||||||
| 03/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Oncology | ||||||
| 03/15/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Inflammation | ||||||
| 02/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Obesity | ||||||
| 01/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Cardiovascular | ||||||
| 11/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/03/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/22/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Cardiovascular | ||||||
| 09/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Oncology | ||||||
| 07/14/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.32 | General |
| Category: Cardiovascular | ||||||
| 06/23/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.50 | General |
| 06/02/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/20/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: Cardiovascular | ||||||
| 01/18/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.75 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 749 | 925 | $179,750 | $36,080 |
| 2022 | 13 | 917 | 1,126 | $202,822 | $39,741 |
| 2021 | 16 | 1,476 | 1,738 | $213,590 | $60,803 |
| 2020 | 16 | 719 | 1,059 | $202,404 | $56,219 |
Total Patients
3,861
Total Services
4,848
Medicare Billing
$192,843
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 198 | $37,620 | $7,766 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 184 | $52,256 | $7,640 | 14.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 116 | 116 | $39,788 | $5,087 | 12.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,585 | $3,946 | 86.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 80 | $30,640 | $3,416 | 11.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 40 | $3,200 | $2,864 | 89.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 104 | 104 | $4,888 | $1,834 | 37.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $2,522 | $1,710 | 67.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 45 | $2,835 | $1,329 | 46.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $882.00 | $413.56 | 46.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 18 | $144.00 | $57.97 | 40.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 14 | 15 | $390.00 | $16.48 | 4.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 251 | $47,690 | $9,871 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 209 | $59,356 | $8,728 | 14.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 122 | 122 | $41,846 | $5,053 | 12.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 56 | 57 | $4,585 | $3,890 | 84.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 68 | $26,044 | $3,215 | 12.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 128 | 128 | $6,016 | $2,303 | 38.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 122 | 122 | $3,172 | $2,155 | 67.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 57 | 58 | $3,654 | $1,639 | 44.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 35 | $4,060 | $1,285 | 31.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 18 | 20 | $1,100 | $717.22 | 65.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $3,960 | $467.76 | 11.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 14 | 15 | $585.00 | $376.76 | 64.4% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 29 | 29 | $754.00 | $39.70 | 5.3% |
About Dr. Patricia Buchanan, M.D
Dr. Patricia Buchanan, M.D is a Family Medicine healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487768859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patricia Buchanan, M.D has received a total of $5,323 in payments from pharmaceutical and medical device companies, with $224.36 received in 2024. These payments were reported across 348 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,301).
As a Medicare-enrolled provider, Buchanan has provided services to 3,861 Medicare beneficiaries, totaling 4,848 services with total Medicare billing of $192,843. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Eugene, OR
- Active Since 08/19/2006
- Last Updated 09/23/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487768859
Products in Payments
- ELIQUIS (Drug) $571.80
- FARXIGA (Drug) $548.30
- CHANTIX (Drug) $475.14
- SYMBICORT (Drug) $265.15
- Livalo (Drug) $171.32
- ENTRESTO (Drug) $169.16
- Prolia (Biological) $166.74
- JANUVIA (Drug) $132.87
- VRAYLAR (Drug) $126.28
- EVENITY (Biological) $125.05
- BEXSERO (Biological) $121.74
- XARELTO (Drug) $118.74
- BEVESPI AEROSPHERE (Drug) $102.61
- Aimovig (Biological) $100.07
- TRULICITY (Drug) $96.96
- VIAGRA (Drug) $91.92
- TOVIAZ (Drug) $89.23
- Cologuard Collection Kit (Device) $69.07
- BYDUREON (Drug) $66.08
- QVAR (Drug) $63.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Eugene
Randy Reese, Md, MD
Family Medicine — Payments: $9,360
Family Medicine $9,360
Hylke Snieder, M.d, M.D
Family Medicine — Payments: $4,297
Family Medicine $4,297
David Kobliska, M.d, M.D
Family Medicine — Payments: $2,949
Family Medicine $2,949
Doherty Gilchrist, Md, MD
Family Medicine — Payments: $1,786
Family Medicine $1,786
Dr. Neema Reddy, Md, MD
Family Medicine — Payments: $1,592
Family Medicine $1,592
Kathleen Cordes, Md, MD
Family Medicine — Payments: $1,452
Family Medicine $1,452